# Polyarthritis spectrum disorders managed by ayurvedic formulation arthocon: A clinical case series

## TL;DR

This study shows that an Ayurvedic treatment called Arthocon improved joint symptoms in patients with various types of arthritis over 12 weeks.

## Contribution

The study presents a novel integrative Ayurvedic treatment for managing multiple types of polyarthritis with minimal side effects.

## Key findings

- Mean joint count decreased from 11.5 to 3.8 after 12 weeks of treatment.
- Disease activity scores like DAS28, PASDAS, and SLEDAI showed significant reductions.
- Pain scores and swelling indices improved across different arthritis types without major adverse effects.

## Abstract

Polyarthritis encompasses a broad range of joint disorders, including autoimmune, degenerative and crystal-induced types. Conventional
treatments often involve long-term NSAIDs or immunosuppressants, with significant side effects. In this case series, fifteen adult
patients (age 29 to 63 years; both male and female) with confirmed diagnoses of RA, PsA, SLE, AS, OA and polyarticular gout were
enrolled and treated with ArthoconTM Capsule (500 mg BID) and topical ArthoconTM Oil for 12 weeks. Mean joint count decreased from 11.5
to 3.8, swelling index from 8.9 to 2.1 and VAS pain scores from 7.3 to 2.8. Disease activity scores improved significantly: DAS28 (mean
reduction 2.9), PASDAS (mean reduction 3.2), SLEDAI (mean reduction 6.0), BASDAI (mean reduction 3.1), WOMAC (mean reduction 34.7) and
SUA in gout patients (mean reduction 1.9 mg/dL) without any major adverse effects. The Ayurvedic combination of ArthoconTM Capsule and
Oil demonstrated promising results across different arthritis types, suggesting its potential as a safe and effective integrative
approach in the management of chronic joint disorders.